BioCentury
ARTICLE | Clinical News

Granisetron extended release regulatory update

September 28, 2015 7:00 AM UTC

FDA accepted for review an NDA from Heron for Sustol granisetron extended release to prevent acute and delayed chemotherapy-induced nausea and vomiting (CINV) associated with moderately or highly emet...